🇺🇸 Hycodan in United States

FDA authorised Hycodan on 23 March 1943

Marketing authorisations

FDA — authorised 23 March 1943

  • Marketing authorisation holder: ENDO PHARMS
  • Status: approved

FDA — authorised 23 March 1943

  • Application: NDA005213
  • Marketing authorisation holder: GENUS
  • Local brand name: HYCODAN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

Hycodan in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Gastroenterology approved in United States

Frequently asked questions

Is Hycodan approved in United States?

Yes. FDA authorised it on 23 March 1943; FDA authorised it on 23 March 1943.

Who is the marketing authorisation holder for Hycodan in United States?

ENDO PHARMS holds the US marketing authorisation.